| Dr Brian Scott Van Voorhis, DDS | |
|
398 Ne Norton Ln, Mcminnville, OR 97128-8481 | |
| (503) 569-0953 | |
| (503) 463-6141 |
| Full Name | Dr Brian Scott Van Voorhis |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 398 Ne Norton Ln, Mcminnville, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164417408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | D7405 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Scott Van Voorhis, DDS 7551 Charolais St Ne, Keizer, OR 97303-1893 Ph: (503) 463-6141 | Dr Brian Scott Van Voorhis, DDS 398 Ne Norton Ln, Mcminnville, OR 97128-8481 Ph: (503) 569-0953 |
News Archive
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has acquired CircuLite, Inc. – developer of the SYNERGY Circulatory Support System, designed to treat less sick, ambulatory, chronic heart failure patients who are not yet inotrope-dependent.
Public Health Week, April 7-13, annually highlights health promotion, disease prevention, and early intervention, but for the faculty and students at the Johns Hopkins University School of Nursing (JHUSON), every week is public health week.
A review published in Phytotherapy Research discussed the natural anti-SARS-CoV-2 products identified based on in silico prediction. The review's authors also illustrate the impact of many phytochemicals either alone or in combination with traditional treatments and their potential molecular mechanisms involved in SARS-CoV-2 prevention and treatment.
A Yale Cancer Center clinical trial combining the immune checkpoint inhibitor (durvalumab/MEDI4736) with chemotherapy as preoperative treatment for early stage triple negative breast cancer disclosed a 71% pathologic complete response to the combination treatment in the initial phase I trial.
Internationally-recognized cancer clinician and researcher Takami Sato, M.D., Ph.D., who serves as the Director of the Metastatic Uveal Melanoma Program in the Department of Medical Oncology at Thomas Jefferson University, has been named the first K. Hasumi Professor of Medical Oncology.
› Verified 9 days ago
Ann Marie Hofbauer, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2260 Sw 2nd St, Mcminnville, OR 97128 Phone: 503-474-9888 Fax: 503-474-9889 | |
Ingrid Marika Viljak, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 819 Ne Baker St, Mcminnville, OR 97128 Phone: 503-472-7900 Fax: 503-474-1819 | |
Mailyn Elizabeth Switzer, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 344 Ne Galloway St, Mcminnville, OR 97128 Phone: 503-472-7592 Fax: 503-435-0551 | |
Dr. Kenneth Dean Wylie, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 325 Ne 6th St, Mcminnville, OR 97128 Phone: 503-472-6182 | |
Lauryn E Marks, DMD Dentist Medicare: Medicare Enrolled Practice Location: 510 Ne 8th St, Mcminnville, OR 97128 Phone: 503-472-3147 | |
Katimarie Ralston, DDS Dentist Medicare: Medicare Enrolled Practice Location: 115 Ne May Ln, Mcminnville, OR 97128 Phone: 503-883-4075 Fax: 503-883-4764 |